{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:31:16Z","timestamp":1776277876249,"version":"3.50.1"},"reference-count":196,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004040","name":"KU Leuven","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004040","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine &amp; Growth Factor Reviews"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.cytogfr.2019.10.006","type":"journal-article","created":{"date-parts":[[2019,10,28]],"date-time":"2019-10-28T02:50:59Z","timestamp":1572231059000},"page":"29-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection"],"prefix":"10.1016","volume":"50","author":[{"given":"Sara","family":"Abouelasrar Salama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muriel","family":"Lavie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mieke","family":"De Buck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sofie","family":"Struyf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cytogfr.2019.10.006_bib0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1478-3231.2008.01925.x","article-title":"Discovery of the hepatitis C virus","volume":"29","author":"Houghton","year":"2009","journal-title":"Liver Int."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","author":"Blach","year":"2017","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0015","doi-asserted-by":"crossref","first-page":"9633","DOI":"10.3748\/wjg.v20.i29.9633","article-title":"Hepatitis C virus in the new era: perspectives in epidemiology, prevention, diagnostics and predictors of response to therapy","volume":"20","author":"Ansaldi","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.5582\/bst.2017.01293","article-title":"Direct-acting agents for hepatitis C virus before and after liver transplantation","volume":"11","author":"Sugawara","year":"2017","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0025","doi-asserted-by":"crossref","first-page":"186","DOI":"10.4254\/wjh.v10.i2.186","article-title":"Hepatitis C virus: morphogenesis, infection and therapy","volume":"10","author":"Morozov","year":"2018","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0030","first-page":"113","article-title":"Hepatitis C virus proteins: from structure to function","author":"Moradpour","year":"2013","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0035","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3390\/cells8040376","article-title":"Hepatitis C virus infection: host\u2013virus interaction and mechanisms of viral persistence","volume":"8","author":"Chigbu","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0040","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3390\/v9080224","article-title":"Hepatitis C virus-induced autophagy and host innate immune response","volume":"9","author":"Chan","year":"2017","journal-title":"Viruses"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0045","doi-asserted-by":"crossref","first-page":"274","DOI":"10.3390\/cells8030274","article-title":"Strategies to circumvent host innate immune response by hepatitis C virus","volume":"8","author":"Patra","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0050","doi-asserted-by":"crossref","first-page":"6025","DOI":"10.1073\/pnas.0607026104","article-title":"Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C","volume":"104","author":"Pestka","year":"2007","journal-title":"Proc. Natl. Acad. Sci U. S. A."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0055","first-page":"45","article-title":"Spontaneous elimination of hepatitis C virus infection","author":"Janiak","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0060","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.3389\/fmicb.2017.02692","article-title":"Designing a B cell-based vaccine against a highly variable hepatitis C virus","volume":"8","author":"Fuerst","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0065","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/v10110645","article-title":"HCV-specific T cell responses during and after chronic HCV infection","volume":"10","author":"Luxenburger","year":"2018","journal-title":"Viruses"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0070","doi-asserted-by":"crossref","first-page":"6128","DOI":"10.1128\/JVI.02627-06","article-title":"Human serum amyloid A protein inhibits hepatitis C virus entry into cells","volume":"81","author":"Cai","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0075","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1002\/hep.21406","article-title":"Serum amyloid A has antiviral activity against hepatitis C virus by inhibiting virus entry in a cell culture system","volume":"44","author":"Lavie","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0080","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0145-305X(02)00068-X","article-title":"Lipopolysaccharides induce intestinal serum amyloid A expression in the sea cucumber Holothuria glaberrima","volume":"27","author":"Santiago-Cardona","year":"2003","journal-title":"Dev. Comp. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0085","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.2174\/0929867323666160418114600","article-title":"Structure and expression of different serum amyloid A (SAA) variants and their concentration-dependent functions during host insults","volume":"23","author":"De Buck","year":"2016","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0090","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s10020-018-0047-0","article-title":"Serum amyloid A - a review","volume":"24","author":"Sack","year":"2018","journal-title":"Mol. Med."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0095","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","article-title":"Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease","volume":"1843","author":"Turner","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0100","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1099\/vir.0.034033-0","article-title":"Hepatitis C virus activates interleukin-1\u03b2 via caspase-1-inflammasome complex","volume":"93","author":"Burdette","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0105","doi-asserted-by":"crossref","first-page":"12284","DOI":"10.1128\/JVI.01962-13","article-title":"Hepatitis C virus induces interleukin-1\u03b2 (IL-1\u03b2)\/IL-18 in circulatory and resident liver macrophages","volume":"87","author":"Shrivastava","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0110","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/hep.26128","article-title":"Hepatitis C virus promotes T-helper (Th)17 responses through thymic stromal lymphopoietin production by infected hepatocytes","volume":"57","author":"Lee","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0115","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s11095-013-1050-3","article-title":"HCV J6\/JFH1 tilts the capability of myeloid-derived dendritic cells to favor the induction of immunosuppression and Th17-related inflammatory cytokines","volume":"32","author":"Fang","year":"2015","journal-title":"Pharm. Res."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0120","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/jcmm.12801","article-title":"Hepatitis C virus NS3-4A inhibits the peroxisomal MAVS-dependent antiviral signalling response","volume":"20","author":"Ferreira","year":"2016","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0125","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1073\/pnas.0408824102","article-title":"Immune evasion by hepatitis C virus NS3\/4A protease-mediated cleavage of the toll-like receptor 3 adaptor protein TRIF","volume":"102","author":"Li","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature07106","article-title":"Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA","volume":"454","author":"Saito","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0135","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1189\/jlb.0207128","article-title":"Toll-like receptors 1 and 6 are involved in TLR2-mediated macrophage activation by hepatitis C virus core and NS3 proteins","volume":"82","author":"Chang","year":"2007","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0140","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2004.08.067","article-title":"Hepatitis C core and nonstructural 3 proteins trigger toll-like receptor 2-mediated pathways and inflammatory activation","volume":"127","author":"Dolganiuc","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0145","doi-asserted-by":"crossref","first-page":"e0131346","DOI":"10.1371\/journal.pone.0131346","article-title":"Substitution in amino acid 70 of hepatitis C virus core protein changes the adipokine profile via toll-like receptor 2\/4 signaling","volume":"10","author":"Uraki","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0150","doi-asserted-by":"crossref","first-page":"e0125419","DOI":"10.1371\/journal.pone.0125419","article-title":"Hepatitis C virus NS3 mediated microglial inflammation via TLR2\/TLR6 MyD88\/NF-\u03baB pathway and toll like receptor ligand treatment furnished immune tolerance","volume":"10","author":"Rajalakshmy","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0155","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1007\/s10620-010-1395-y","article-title":"HCV-related proteins activate kupffer cells isolated from human liver tissues","volume":"56","author":"Hosomura","year":"2011","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0160","doi-asserted-by":"crossref","first-page":"e1001184","DOI":"10.1371\/journal.ppat.1001184","article-title":"Hepatitis C virus (HCV) evades NKG2D-dependent NK cell responses through NS5A-mediated imbalance of inflammatory cytokines","volume":"6","author":"S\u00e8ne","year":"2010","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0165","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.24763","article-title":"Activation of chemokine and inflammatory cytokine response in hepatitis C virus-infected hepatocytes depends on toll-like receptor 3 sensing of hepatitis C virus double-stranded RNA intermediates","volume":"55","author":"Li","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0170","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaut.2008.08.001","article-title":"HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity","volume":"31","author":"Akeno","year":"2008","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0175","doi-asserted-by":"crossref","first-page":"8079","DOI":"10.1128\/JVI.79.13.8079-8089.2005","article-title":"Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B cells","volume":"79","author":"Machida","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0180","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2893.2004.00545.x","article-title":"Binding of HCV E2 to CD81 induces RANTES secretion and internalization of CC chemokine receptor 5","volume":"11","author":"Nattermann","year":"2004","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0185","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1016\/j.lfs.2003.08.025","article-title":"Interleukin-18 induces serum amyloid A (SAA) protein production from rheumatoid synovial fibroblasts","volume":"74","author":"Tanaka","year":"2004","journal-title":"Life Sci."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0190","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00405-012-2295-x","article-title":"Interleukin-17A contributes to the expression of serum amyloid A in chronic rhinosinusitis with nasal polyps","volume":"270","author":"Wang","year":"2013","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0195","doi-asserted-by":"crossref","first-page":"e0181486","DOI":"10.1371\/journal.pone.0181486","article-title":"Interleukin-17A-induced production of acute serum amyloid A by keratinocytes contributes to psoriasis pathogenesis","volume":"12","author":"Couderc","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0200","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/002215540405200104","article-title":"Expression of cytokines (TNF-\u03b1, IL-1\u03b1, and IL-2) in chronic hepatitis C: comparative hybridocytochemical and immunocytochemical study in children and adult patients","volume":"52","author":"Kasprzak","year":"2004","journal-title":"J. Histochem. Cytochem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0205","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1093\/infdis\/jir642","article-title":"High plasma interleukin-18 levels mark the acute phase of hepatitis C virus infection","volume":"204","author":"Chattergoon","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0210","doi-asserted-by":"crossref","first-page":"e514","DOI":"10.1111\/j.1365-2567.2008.03021.x","article-title":"Elevation of interleukin-18 in chronic hepatitis C: implications for hepatitis C virus pathogenesis","volume":"128","author":"Sharma","year":"2009","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0215","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jmv.21079","article-title":"Association of interleukin-18 polymorphisms and plasma level with the outcome of chronic HCV infection","volume":"80","author":"Bouzgarrou","year":"2008","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0220","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17071070","article-title":"Involvement of the interleukin-23\/interleukin-17 Axis in chronic hepatitis C virus infection and its treatment responses","volume":"17","author":"Meng","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0225","doi-asserted-by":"crossref","first-page":"242","DOI":"10.4254\/wjh.v4.i8.242","article-title":"Relationship between vitamin D and IL-23, IL-17 and macrophage chemoattractant protein-1 as markers of fibrosis in hepatitis C virus Egyptians","volume":"4","author":"El Husseiny","year":"2012","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0230","doi-asserted-by":"crossref","first-page":"380","DOI":"10.3109\/1547691X.2012.758198","article-title":"Circulating IL-6, IL-17 and vitamin D in hepatocellular carcinoma: Potential biomarkers for a more favorable prognosis","volume":"10","author":"Hammad","year":"2013","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0235","doi-asserted-by":"crossref","first-page":"562","DOI":"10.3748\/wjg.v8.i3.562","article-title":"HCV-specific cytokine induction in monocytes of patients with different outcomes of hepatitis C","volume":"8","author":"Woitas","year":"2002","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0240","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1158\/1078-0432.CCR-06-0154","article-title":"Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin\u2019s lymphoma","volume":"12","author":"Feldmann","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.febslet.2004.05.072","article-title":"Lipopolysaccharide signaling induces serum amyloid A (SAA) synthesis in human hepatocytes in vitro","volume":"569","author":"Migita","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0250","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.cyto.2015.06.017","article-title":"The interleukin (IL)-1 cytokine family \u2013 balance between agonists and antagonists in inflammatory diseases","volume":"76","author":"Palomo","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0255","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.tibs.2016.09.002","article-title":"Mechanism and regulation of NLRP3 inflammasome activation","volume":"41","author":"He","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0260","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s10875-010-9440-3","article-title":"Molecular mechanism of NLRP3 inflammasome activation","volume":"30","author":"Jin","year":"2010","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0265","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.bbadis.2016.12.006","article-title":"The p7 viroporin of the hepatitis C virus contributes to liver inflammation by stimulating production of Interleukin-1\u03b2","volume":"1863","author":"Farag","year":"2017","journal-title":"Biochim. Biophys. Acta. Mol. Basis Dis."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0270","doi-asserted-by":"crossref","first-page":"e84953","DOI":"10.1371\/journal.pone.0084953","article-title":"HCV genomic RNA activates the NLRP3 inflammasome in human myeloid cells","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0275","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/hep.29170","article-title":"Hepatitis C virus-induced CCL5 secretion from macrophages activates hepatic stellate cells","volume":"66","author":"Sasaki","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0280","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/nri.2017.50","article-title":"The dichotomous nature of T helper 17 cells","volume":"17","author":"Stockinger","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0285","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1146\/annurev.immunol.021908.132710","article-title":"IL-17 and Th17 cells","volume":"27","author":"Korn","year":"2009","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0290","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1440-1746.2011.06782.x","article-title":"Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C","volume":"27","author":"Chang","year":"2012","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0295","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/imm.12720","article-title":"The proportion of different interleukin-17-producing T-cell subsets is associated with liver fibrosis in chronic hepatitis C","volume":"151","author":"Cachem","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0300","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s10620-011-1997-z","article-title":"Interleukin (IL)-17\/IL-22-producing T cells enriched within the liver of patients with chronic hepatitis C viral (HCV) infection","volume":"57","author":"Foster","year":"2012","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0305","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000343369","article-title":"Thymic stromal lymphopoietin over-expressed in human atherosclerosis: potential role in Th17 differentiation","volume":"31","author":"Lin","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0310","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1128\/JVI.03376-12","article-title":"Differential regulation of interleukin-12 (IL-12)\/IL-23 by Tim-3 drives T(H)17 cell development during hepatitis C virus infection","volume":"87","author":"Wang","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0315","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.rvsc.2013.08.006","article-title":"Activation of NF-\u03baB contributes to production of pig-major acute protein and serum amyloid A in pigs experimentally infected with porcine circovirus type 2","volume":"95","author":"Lv","year":"2013","journal-title":"Res. Vet. Sci."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0320","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.antiviral.2016.08.011","article-title":"Serum amyloid A (SAA) is an early biomarker of influenza virus disease in BALB\/c, C57BL\/2, Swiss-Webster, and DBA.2 mice","volume":"133","author":"Vollmer","year":"2016","journal-title":"Antiviral Res."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0325","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1746-6148-9-14","article-title":"C-reactive protein, haptoglobin, serum amyloid A and pig major acute phase protein response in pigs simultaneously infected with H1N1 swine influenza virus and Pasteurella multocida","volume":"9","author":"Pomorska-M\u00f3l","year":"2013","journal-title":"BMC Vet. Res."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0330","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/infdis\/146.3.443","article-title":"Serum amyloid A levels in patients with infections due to cytomegalovirus, varicella-zoster virus, and herpes simplex virus","volume":"146","author":"Sarov","year":"1982","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0335","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1136\/adc.68.2.210","article-title":"Serum amyloid A protein in acute viral infections","volume":"68","author":"Miwata","year":"1993","journal-title":"Arch. Dis. Child."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0340","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/his.13016","article-title":"Serum amyloid A immunohistochemical staining patterns in hepatitis","volume":"69","author":"Piotti","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0345","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1074\/jbc.M405009200","article-title":"Serum amyloid A binding to CLA-1 (CD36 and LIMPII Analogous-1) mediates serum amyloid A protein-induced activation of ERK1\/2 and p38 Mitogen-activated protein kinases","volume":"280","author":"Baranova","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0350","doi-asserted-by":"crossref","first-page":"35890","DOI":"10.1074\/jbc.M505685200","article-title":"Serum amyloid A promotes cholesterol efflux mediated by scavenger receptor B-I","volume":"280","author":"Van der Westhuyzen","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0355","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1182\/blood-2006-03-009266","article-title":"Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation","volume":"108","author":"Bozza","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0360","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s10875-005-8065-4","article-title":"Innate sensors of microbial infection","volume":"25","author":"Hargreaves","year":"2005","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0365","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1182\/blood-2005-11-011932","article-title":"Serum amyloid A is an innate immune opsonin for gram-negative bacteria","volume":"108","author":"Shah","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0370","first-page":"387","article-title":"Secondary structure prediction of human SAA1. Presumptive identification of calcium and lipid binding sites","volume":"3","author":"Turnell","year":"1986","journal-title":"Mol. Biol. Med."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0375","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1042\/bj2560775","article-title":"Circular-dichroism studies on two murine serum amyloid A proteins","volume":"256","author":"McCubbin","year":"1988","journal-title":"Biochem. J."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0380","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13506120412331272296","article-title":"Hypothetical structure of human serum amyloid A protein","volume":"11","author":"Stevens","year":"2004","journal-title":"Amyloid"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0385","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1073\/pnas.1322357111","article-title":"Structural mechanism of serum amyloid A-mediated inflammatory amyloidosis","volume":"111","author":"Lu","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0390","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1002\/1873-3468.12116","article-title":"Structure of serum amyloid A suggests a mechanism for selective lipoprotein binding and functions: SAA as a hub in macromolecular interaction networks","volume":"590","author":"Frame","year":"2016","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0395","doi-asserted-by":"crossref","first-page":"4025","DOI":"10.1073\/pnas.74.9.4025","article-title":"Amyloid protein SAA is associated with high density lipoprotein from human serum","volume":"74","author":"Benditt","year":"1977","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0400","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1073\/pnas.76.8.4092","article-title":"Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein","volume":"76","author":"Benditt","year":"1979","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0405","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/385214","article-title":"Proteomic analysis of plasma-purified VLDL, LDL, and HDL fractions from atherosclerotic patients undergoing carotid endarterectomy: identification of serum amyloid A as a potential marker","volume":"2013","author":"Lepedda","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0410","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/oby.20126","article-title":"Serum amyloid A is found on ApoB-containing lipoproteins in obese humans with diabetes","volume":"21","author":"Jahangiri","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0415","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.mehy.2005.10.018","article-title":"Rapid recycling of cholesterol: the joint biologic role of C-reactive protein and serum amyloid A","volume":"66","author":"Manley","year":"2006","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0420","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1074\/jbc.M411555200","article-title":"Serum amyloid A is a ligand for scavenger receptor class B type I and inhibits high density lipoprotein binding and selective lipid uptake","volume":"280","author":"Cai","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0425","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/gutjnl-2016-311726","article-title":"Ultrastructural organisation of HCV from the bloodstream of infected patients revealed by electron microscopy after specific immunocapture","volume":"66","author":"Piver","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0430","doi-asserted-by":"crossref","first-page":"6919","DOI":"10.1128\/JVI.76.14.6919-6928.2002","article-title":"Characterization of low- and very-low-density hepatitis C virus RNA-containing particles","volume":"76","author":"Andr\u00e9","year":"2002","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0435","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1128\/jvi.67.4.1953-1958.1993","article-title":"Equilibrium centrifugation studies of hepatitis C virus: evidence for circulating immune complexes","volume":"67","author":"Hijikata","year":"1993","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0440","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1074\/jbc.M110.175018","article-title":"Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome","volume":"286","author":"Merz","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0445","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/bs.pmbts.2014.10.003","article-title":"The mechanism of HCV entry into host cells","author":"Douam","year":"2015","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0450","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0455","doi-asserted-by":"crossref","first-page":"31242","DOI":"10.1074\/jbc.M112.365924","article-title":"Characterization of hepatitis C virus particle subpopulations reveals multiple usage of the scavenger receptor BI for entry steps","volume":"287","author":"Dao Thi","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0460","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.biochi.2017.06.009","article-title":"Interplay between hepatitis C virus and lipid metabolism during virus entry and assembly","volume":"141","author":"Lavie","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0465","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1128\/JVI.01063-10","article-title":"Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms","volume":"84","author":"Hishiki","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0470","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.virol.2009.08.037","article-title":"Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor","volume":"394","author":"Owen","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0475","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.25501","article-title":"Role of low-density lipoprotein receptor in the hepatitis C virus life cycle","volume":"55","author":"Albecka","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0480","doi-asserted-by":"crossref","first-page":"e1005610","DOI":"10.1371\/journal.ppat.1005610","article-title":"Lipoprotein receptors redundantly participate in entry of hepatitis C virus","volume":"12","author":"Yamamoto","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0485","doi-asserted-by":"crossref","first-page":"13783","DOI":"10.1128\/JVI.01091-07","article-title":"Human apolipoprotein E is required for infectivity and production of hepatitis C virus in cell culture","volume":"81","author":"Chang","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0490","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1128\/JVI.02053-07","article-title":"Cellular determinants of hepatitis C virus assembly, maturation, degradation, and secretion","volume":"82","author":"Gastaminza","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0495","doi-asserted-by":"crossref","first-page":"5848","DOI":"10.1073\/pnas.0700760104","article-title":"Hepatitis C virus production by human hepatocytes dependent on assembly and secretion of very low-density lipoproteins","volume":"104","author":"Huang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0500","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1099\/vir.0.81932-0","article-title":"High-density lipoproteins reduce the neutralizing effect of hepatitis C virus (HCV)-infected patient antibodies by promoting HCV entry","volume":"87","author":"Voisset","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0505","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1084\/jem.20021756","article-title":"Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes","volume":"197","author":"Bartosch","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0510","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S0014-5793(03)00635-5","article-title":"Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins","volume":"546","author":"Drummer","year":"2003","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0515","doi-asserted-by":"crossref","first-page":"8217","DOI":"10.1128\/JVI.79.13.8217-8229.2005","article-title":"An interplay between hypervariable region 1 of the hepatitis C virus E2 glycoprotein, the scavenger receptor BI, and high-density lipoprotein promotes both enhancement of infection and protection against neutralizing antibodies","volume":"79","author":"Bartosch","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0520","doi-asserted-by":"crossref","first-page":"4560","DOI":"10.1073\/pnas.0501275102","article-title":"Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1","volume":"102","author":"Meunier","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0525","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1096\/fj.05-4728fje","article-title":"The interaction of natural hepatitis C virus with human scavenger receptor SR-BI\/Cla1 is mediated by ApoB-containing lipoproteins","volume":"20","author":"Maillard","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0530","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1099\/vir.0.81646-0","article-title":"Hepatitis C virus entry: potential receptors and their biological functions","volume":"87","author":"Cocquerel","year":"2006","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0535","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M602706200","article-title":"High density lipoprotein inhibits hepatitis C virus neutralising antibodies by stimulating cell entry via activation of the scavenger receptor BI","author":"Dreux","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0540","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1017\/S1462399411001785","article-title":"Scavenger receptor class B type I and the hypervariable region-1 of hepatitis C virus in cell entry and neutralisation","volume":"13","author":"Dao Thi","year":"2011","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0545","doi-asserted-by":"crossref","first-page":"9505","DOI":"10.1073\/pnas.1307527110","article-title":"Ultrastructural analysis of hepatitis C virus particles","volume":"110","author":"Catanese","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0550","doi-asserted-by":"crossref","first-page":"9647","DOI":"10.1128\/JVI.00914-08","article-title":"Apolipoprotein c1 association with hepatitis C virus","volume":"82","author":"Meunier","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0555","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s004300000032","article-title":"Binding of human lipoproteins (low, very low, high density lipoproteins) to recombinant envelope proteins of hepatitis C virus","volume":"188","author":"Monazahian","year":"2000","journal-title":"Med. Microbiol. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0560","doi-asserted-by":"crossref","first-page":"20625","DOI":"10.1074\/jbc.M111020200","article-title":"Reconstitution of hepatitis C virus envelope glycoproteins into liposomes as a surrogate model to study virus attachment","volume":"277","author":"Lambot","year":"2002","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0565","doi-asserted-by":"crossref","first-page":"12422","DOI":"10.1128\/JVI.01660-14","article-title":"Apolipoprotein E likely contributes to a maturation step of infectious hepatitis C virus particles and interacts with viral envelope glycoproteins","volume":"88","author":"Lee","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0570","doi-asserted-by":"crossref","first-page":"11532","DOI":"10.1128\/JVI.01021-10","article-title":"The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus","volume":"84","author":"Cun","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0575","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/hep.23278","article-title":"Apolipoprotein E interacts with hepatitis C virus nonstructural protein 5A and determines assembly of infectious particles","volume":"51","author":"Benga","year":"2010","journal-title":"Hepatology."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0580","doi-asserted-by":"crossref","first-page":"18904","DOI":"10.1074\/jbc.M113.538256","article-title":"The association of hepatitis C virus glycoproteins with apolipoproteins E and B early in assembly is conserved in lipoviral particles","volume":"289","author":"Boyer","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0585","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.4049\/jimmunol.1800503","article-title":"Bacterial lipoproteins constitute the TLR2-stimulating activity of serum amyloid A","volume":"201","author":"Burgess","year":"2018","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0590","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nri3623","article-title":"Liver fibrosis and repair: immune regulation of wound healing in a solid organ","volume":"14","author":"Pellicoro","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0595","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/art.21518","article-title":"Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-\u03baB\u2013dependent signal transduction pathway","volume":"54","author":"Mullan","year":"2006","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0600","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.3748\/wjg.v9.i7.1409","article-title":"Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma","volume":"9","author":"Ding","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0605","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.4049\/jimmunol.177.8.5585","article-title":"Serum amyloid A binding to formyl peptide receptor-like 1 induces synovial hyperplasia and angiogenesis","volume":"177","author":"Lee","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0610","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.4049\/jimmunol.0902941","article-title":"Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis\/SCID mouse chimera model","volume":"184","author":"Connolly","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0615","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1136\/ard.2010.142240","article-title":"Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritis","volume":"70","author":"Connolly","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0620","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1136\/annrheumdis-2015-207655","article-title":"Acute serum amyloid A is an endogenous TLR2 ligand that mediates inflammatory and angiogenic mechanisms","volume":"75","author":"Connolly","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0625","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.molimm.2015.03.254","article-title":"An involvement of SR-B1 mediated p38 MAPK signaling pathway in serum amyloid A-induced angiogenesis in rheumatoid arthritis","volume":"66","author":"Hong","year":"2015","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0630","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13105-015-0462-4","article-title":"Serum amyloid A stimulates vascular endothelial growth factor receptor 2 expression and angiogenesis","volume":"72","author":"Lv","year":"2016","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0635","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1002\/hep.28526","article-title":"Platelets: no longer bystanders in liver disease","volume":"64","author":"Chauhan","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0640","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/apm.12574","article-title":"Platelets contribute to growth and metastasis in hepatocellular carcinoma","volume":"124","author":"Bihari","year":"2016","journal-title":"APMIS"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0645","first-page":"180","article-title":"Serum amyloid A, an acute phase protein, inhibits platelet activation","volume":"116","author":"Zimlichman","year":"1990","journal-title":"J. Lab. Clin. Med."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0650","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1182\/blood.V99.4.1224","article-title":"Adhesion of human platelets to serum amyloid A","volume":"99","author":"Urieli-Shoval","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0655","doi-asserted-by":"crossref","first-page":"7260","DOI":"10.3748\/wjg.v20.i23.7260","article-title":"Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: an update","volume":"20","author":"Elpek","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0660","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/cmi.2014.2","article-title":"The role of neutrophils in the development of liver diseases","volume":"11","author":"Xu","year":"2014","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0665","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1189\/jlb.3A0315-085R","article-title":"Serum amyloid A1\u03b1 induces paracrine IL-8\/CXCL8 via TLR2 and directly synergizes with this chemokine via CXCR2 and formyl peptide receptor 2 to recruit neutrophils","volume":"98","author":"De Buck","year":"2015","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0670","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1084\/jem.180.1.203","article-title":"Serum amyloid A is a chemoattractant: induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes","volume":"180","author":"Badolato","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0675","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.4049\/jimmunol.155.8.4004","article-title":"Serum amyloid A induces calcium mobilization and chemotaxis of human monocytes by activating a pertussis toxin-sensitive signaling pathway","volume":"155","author":"Badolato","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0680","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/eji.201444818","article-title":"Serum amyloid A chemoattracts immature dendritic cells and indirectly provokes monocyte chemotaxis by induction of cooperating CC and CXC chemokines","volume":"45","author":"Gouwy","year":"2015","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0685","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.4049\/jimmunol.155.3.1184","article-title":"A novel biologic function of serum amyloid A. Induction of T lymphocyte migration and adhesion","volume":"155","author":"Xu","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0690","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1006\/bbrc.1998.9911","article-title":"Serum amyloid A induces chemotaxis of human mast cells by activating a pertussis toxin-sensitive signal transduction pathway","volume":"254","author":"Olsson","year":"1999","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0695","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3109\/13506120209114099","article-title":"Acute-phase, but not constitutive serum amyloid A (SAA) is chemotactic for cultured human aortic smooth muscle cells","volume":"9","author":"Kumon","year":"2002","journal-title":"Amyloid"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0700","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.imbio.2014.08.002","article-title":"Serum amyloid A1 isoforms display different efficacy at Toll-like receptor 2 and formyl peptide receptor 2","volume":"219","author":"Chen","year":"2014","journal-title":"Immunobiology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0705","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1006\/bbrc.2000.2416","article-title":"Serum amyloid A is a chemotactic agonist at FPR2, a low-affinity N-Formylpeptide receptor on mouse neutrophils","volume":"270","author":"Liang","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0710","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s000180050320","article-title":"Structural properties of matrix metalloproteinases","volume":"55","author":"Bode","year":"1999","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0715","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/art.33455","article-title":"Acute-phase serum amyloid A regulates tumor necrosis factor \u03b1 and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy","volume":"64","author":"Connolly","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0720","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.bbrc.2005.03.069","article-title":"Serum amyloid A stimulates matrix-metalloproteinase-9 upregulation via formyl peptide receptor like-1-mediated signaling in human monocytic cells","volume":"330","author":"Lee","year":"2005","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0725","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.3389\/fimmu.2018.01081","article-title":"Matrix metalloproteinase-9-generated COOH-, but not NH2-terminal fragments of serum amyloid A1 retain potentiating activity in neutrophil migration to CXCL8, with loss of direct chemotactic and cytokine-inducing capacity","volume":"9","author":"Gouwy","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0730","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1159\/000139134","article-title":"Celecoxib inhibits serum amyloid A-induced matrix metalloproteinase-10 expression in human endothelial cells","volume":"46","author":"Zhao","year":"2009","journal-title":"J. Vasc. Res."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0735","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.imlet.2018.06.001","article-title":"The ectoenzyme-side of matrix metalloproteinases (MMPs) makes inflammation by serum amyloid A (SAA) and chemokines go round","volume":"205","author":"De Buck","year":"2019","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0740","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","article-title":"Mechanisms of hepatic stellate cell activation","volume":"14","author":"Tsuchida","year":"2017","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0745","doi-asserted-by":"crossref","first-page":"e0150893","DOI":"10.1371\/journal.pone.0150893","article-title":"Serum amyloid A induces inflammation, proliferation and cell death in activated hepatic stellate cells","volume":"11","author":"Siegmund","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0750","doi-asserted-by":"crossref","first-page":"13","DOI":"10.12703\/P6-13","article-title":"The M1 and M2 paradigm of macrophage activation: time for reassessment","volume":"6","author":"Martinez","year":"2014","journal-title":"F1000Prime Rep."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0755","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1038\/onc.2011.112","article-title":"Pleiotropic regulation of macrophage polarization and tumorigenesis by formyl peptide receptor-2","volume":"30","author":"Li","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0760","doi-asserted-by":"crossref","first-page":"4891","DOI":"10.4049\/jimmunol.1402164","article-title":"Ex vivo and in vitro effect of serum amyloid A in the induction of macrophage M2 markers and efferocytosis of apoptotic neutrophils","volume":"194","author":"Sun","year":"2015","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0765","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1096\/fj.14-250332","article-title":"SAA drives proinflammatory heterotypic macrophage differentiation in the lung via CSF-1R-dependent signaling","volume":"28","author":"Anthony","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0770","doi-asserted-by":"crossref","first-page":"109238","DOI":"10.18632\/oncotarget.22652","article-title":"Serum amyloid a induces M2b-like macrophage polarization during liver inflammation","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0775","first-page":"144","article-title":"Biomarkers in rheumatoid arthritis, what is new?","volume":"9","author":"Gavril\u0103","year":"2016","journal-title":"J. Med. Life"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0780","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/MIB.0000000000000991","article-title":"Serum amyloid A as a surrogate marker for mucosal and histologic inflammation in patients with crohn\u02bcs disease","volume":"23","author":"Yarur","year":"2017","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0785","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1164\/rccm.200905-0696OC","article-title":"Serum amyloid A regulates granulomatous inflammation in sarcoidosis through Toll-like receptor-2","volume":"181","author":"Chen","year":"2010","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0790","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1172\/JCI108949","article-title":"Changes in human serum amyloid A and C-reactive protein after etiocholanolone-induced inflammation","volume":"61","author":"McAdam","year":"1978","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0795","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/cs0680233","article-title":"Comparative study of serum amyloid A protein and C-reactive protein in disease","volume":"68","author":"Maury","year":"1985","journal-title":"Clin. Sci."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0800","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.0954-6820.1986.tb02769.x","article-title":"Serum amyloid A protein in acute myocardial infarction","volume":"220","author":"Marhaug","year":"1986","journal-title":"Acta Med. Scand."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0805","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.tox.2013.01.012","article-title":"Serum amyloid A upsurge precedes standard biomarkers of hepatotoxicity in ritodrine-injected mice","volume":"305","author":"Tsuchiya","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0810","doi-asserted-by":"crossref","first-page":"101","DOI":"10.15403\/jgld-1290","article-title":"Increased levels of serum amyloid A during the early phase of hepatitis C treatment with interferon are associated with sustained virologic response - a pilot study","volume":"23","author":"Gschwantler","year":"2014","journal-title":"J. Gastrointestin. Liver Dis."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0815","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s40880-015-0039-1","article-title":"The prognostic value of serum C-reactive protein-bound serum amyloid A in early-stage lung cancer","volume":"34","author":"Zhang","year":"2015","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0820","first-page":"878","article-title":"SAA1 polymorphisms are associated with variation in antiangiogenic and tumor-suppressive activities in nasopharyngeal carcinoma","volume":"12","author":"Lung","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0825","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1746-1596-9-16","article-title":"Expression of serum amyloid A in uterine cervical cancer","volume":"9","author":"Ren","year":"2014","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0830","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jchromb.2012.01.002","article-title":"Purification, identification and profiling of serum amyloid A proteins from sera of advanced-stage cancer patients","volume":"889\u2013890","author":"Li","year":"2012","journal-title":"J. Chromatogr. B Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0835","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.canlet.2008.04.022","article-title":"Serum amyloid A as indicator of distant metastases but not as early tumor marker in patients with renal cell carcinoma","volume":"269","author":"Ramankulov","year":"2008","journal-title":"Cancer Lett."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0840","doi-asserted-by":"crossref","first-page":"10713","DOI":"10.7314\/APJCP.2014.15.24.10713","article-title":"Serum amyloid A is a novel prognostic biomarker in hepatocellular carcinoma","volume":"15","author":"Ni","year":"2014","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0845","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12935-019-0783-4","article-title":"The prognostic value of serum amyloid A in solid tumors: a meta-analysis","volume":"19","author":"Lin","year":"2019","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0850","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1021\/pr101154j","article-title":"Identification and validation of SAA as a potential lung cancer biomarker and its involvement in metastatic pathogenesis of lung cancer","volume":"10","author":"Sung","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0855","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1016\/S0168-8278(12)60009-9","article-title":"Management of HCC","volume":"56","author":"de Lope","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0860","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jcb.21443","article-title":"Toward the proteomic identification of biomarkers for the prediction of HBV related hepatocellular carcinoma","volume":"103","author":"He","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0865","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/QCO.0000000000000190","article-title":"A new era of therapy for hepatitis C virus infection","volume":"28","author":"Nyalakonda","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0870","doi-asserted-by":"crossref","first-page":"47","DOI":"10.5114\/ceh.2017.67782","article-title":"Recommendations for the treatment of hepatitis C in 2017","volume":"3","author":"Halota","year":"2017","journal-title":"Clin. Exp. Hepatol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0875","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.apsb.2015.09.008","article-title":"Direct anti-HCV agents","volume":"6","author":"Zhang","year":"2016","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0880","doi-asserted-by":"crossref","first-page":"33796","DOI":"10.18632\/oncotarget.9304","article-title":"HCV core protein binds to gC1qR to induce A20 expression and inhibit cytokine production through MAPKs and NF-\u03baB signaling pathways","volume":"7","author":"Song","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0885","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1002\/eji.201243097","article-title":"Upregulation of OX40 ligand on monocytes contributes to early virological control in patients with chronic hepatitis C","volume":"43","author":"Zhang","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0890","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.4049\/jimmunol.177.10.6758","article-title":"Hepatitis C virus (HCV) core protein-induced, monocyte-mediated mechanisms of reduced IFN-alpha and plasmacytoid dendritic cell loss in chronic HCV infection","volume":"177","author":"Dolganiuc","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0895","doi-asserted-by":"crossref","first-page":"e0170516","DOI":"10.1371\/journal.pone.0170516","article-title":"Hepatitis C virus induces MDSCs-like monocytes through TLR2\/PI3K\/AKT\/STAT3 signaling","volume":"12","author":"Zhai","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0900","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1053\/j.gastro.2009.09.009","article-title":"Hepatitis C virus core protein subverts the antiviral activities of human kupffer cells","volume":"138","author":"Tu","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0905","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1016\/j.febslet.2014.08.009","article-title":"Hepatitis C virus core protein enhances HIV-1 replication in human macrophages through TLR2, JNK, and MEK1\/2-dependent upregulation of TNF-\u03b1 and IL-6","volume":"588","author":"Swaminathan","year":"2014","journal-title":"FEBS Lett."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0910","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s13365-011-0039-0","article-title":"Neurotoxic effects of the HCV core protein are mediated by sustained activation of ERK via TLR2 signaling","volume":"17","author":"Paulino","year":"2011","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0915","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1038\/labinvest.2011.78","article-title":"Hepatitis C virus core protein induces fibrogenic actions of hepatic stellate cells via toll-like receptor 2","volume":"91","author":"Coenen","year":"2011","journal-title":"Lab. Investig."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0920","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.exer.2014.09.011","article-title":"HCV core and NS3 proteins mediate toll like receptor induced innate immune response in corneal epithelium","volume":"128","author":"Rajalakshmy","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0925","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1002\/hep.21350","article-title":"Hepatitis C virus E2 and CD81 interaction may be associated with altered trafficking of dendritic cells in chronic hepatitis C","volume":"44","author":"Nattermann","year":"2006","journal-title":"Hepatology."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0930","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.cellimm.2013.07.012","article-title":"Cross-linking of CD81 by HCV-E2 protein inhibits human intrahepatic plasmacytoid dendritic cells response to CpG-ODN","volume":"284","author":"Tu","year":"2013","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0935","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1084\/jem.20011124","article-title":"Inhibition of natural killer cells through engagement of CD81 by the major hepatitis C virus envelope protein","volume":"195","author":"Crotta","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0940","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1084\/jem.20011145","article-title":"Binding of the hepatitis C virus envelope protein E2 to CD81 inhibits natural killer cell functions","volume":"195","author":"Tseng","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0945","doi-asserted-by":"crossref","first-page":"11329","DOI":"10.1074\/jbc.M410161200","article-title":"Binding of hepatitis C virus envelope protein E2 to CD81 up-regulates matrix metalloproteinase-2 in human hepatic stellate cells","volume":"280","author":"Mazzocca","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0950","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.yexcr.2004.12.024","article-title":"Hepatitis C virus E2 protein promotes human hepatoma cell proliferation through the MAPK\/ERK signaling pathway via cellular receptors","volume":"305","author":"Zhao","year":"2005","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0955","doi-asserted-by":"crossref","first-page":"1846","DOI":"10.1002\/hep.24327","article-title":"Hepatitis C virus targets the T cell secretory machinery as a mechanism of immune evasion","volume":"53","author":"Petrovic","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0960","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1189\/jlb.0106014","article-title":"Up-regulation of ERK and p38 MAPK signaling pathways by hepatitis C virus E2 envelope protein in human T lymphoma cell line","volume":"80","author":"Zhao","year":"2006","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0965","doi-asserted-by":"crossref","first-page":"41624","DOI":"10.1074\/jbc.M305289200","article-title":"Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor","volume":"278","author":"Bartosch","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0970","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s12192-013-0405-3","article-title":"ERK signaling is triggered by hepatitis C virus E2 protein through DC-SIGN","volume":"18","author":"Zhao","year":"2013","journal-title":"Cell Stress Chaperones"},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0975","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1073\/pnas.0831128100","article-title":"L-SIGN (CD 209L) is a liver-specific capture receptor for hepatitis C virus","volume":"100","author":"Gardner","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cytogfr.2019.10.006_bib0980","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s12013-012-9505-4","article-title":"Interaction of L-SIGN with hepatitis C virus envelope protein E2 up-regulates raf\u2013MEK\u2013ERK pathway","volume":"66","author":"Zhao","year":"2013","journal-title":"Cell Biochem. Biophys."}],"container-title":["Cytokine &amp; Growth Factor Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610119301054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359610119301054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T10:56:27Z","timestamp":1761216987000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359610119301054"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":196,"alternative-id":["S1359610119301054"],"URL":"https:\/\/doi.org\/10.1016\/j.cytogfr.2019.10.006","relation":{},"ISSN":["1359-6101"],"issn-type":[{"value":"1359-6101","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokines and serum amyloid A in the pathogenesis of hepatitis C virus infection","name":"articletitle","label":"Article Title"},{"value":"Cytokine & Growth Factor Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cytogfr.2019.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}